List of Tables
    Table 1. Recombinant Peptide CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Recombinant Peptide Market Trends
    Table 3. Recombinant Peptide Market Drivers
    Table 4. Recombinant Peptide Market Challenges
    Table 5. Recombinant Peptide Market Restraints
    Table 6. Global Recombinant Peptide Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Recombinant Peptide Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Recombinant Peptide Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Recombinant Peptide Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Recombinant Peptide Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Recombinant Peptide Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Recombinant Peptide Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Recombinant Peptide Sales by Manufacturer, (K Units), 2017-2022
    Table 14. Global Recombinant Peptide Sales Share by Manufacturer, 2017-2022
    Table 15. Global Recombinant Peptide Price by Manufacturer (2017-2022) & (US$/Unit)
    Table 16. Global Recombinant Peptide Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Recombinant Peptide by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Peptide as of 2021)
    Table 18. Top Players of Recombinant Peptide in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Recombinant Peptide Product Type
    Table 20. Date of International Manufacturers Enter into Recombinant Peptide Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Recombinant Peptide Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Recombinant Peptide Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Recombinant Peptide Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Recombinant Peptide Sales by Players, (K Units), 2020, 2021 & 2022
    Table 26. United States Recombinant Peptide Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Recombinant Peptide Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Recombinant Peptide Sales in Volume by Region (2017-2022) & (K Units)
    Table 29. Global Recombinant Peptide Sales in Volume Forecast by Region (2023-2028) & (K Units)
    Table 30. Global Recombinant Peptide Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Recombinant Peptide Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Recombinant Peptide Sales in Volume by Country (2017-2028) & (K Units)
    Table 33. North America Recombinant Peptide Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Recombinant Peptide Sales in Volume by Region (2017-2028) & (K Units)
    Table 35. Asia Pacific Recombinant Peptide Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Recombinant Peptide Sales in Volume by Country (2017-2028) & (K Units)
    Table 37. Europe Recombinant Peptide Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Recombinant Peptide Sales in Volume by Country (2017-2028) & (K Units)
    Table 39. Latin Americaa Recombinant Peptide Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Recombinant Peptide Sales in Volume by Country (2017-2028) & (K Units)
    Table 41. Middle East and Africa Recombinant Peptide Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Sandoz Pharma Corporation Information
    Table 43. Sandoz Pharma Description and Business Overview
    Table 44. Sandoz Pharma Recombinant Peptide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 45. Sandoz Pharma Recombinant Peptide Product
    Table 46. Sandoz Pharma Recent Development
    Table 47. Stada Arzneimittel Corporation Information
    Table 48. Stada Arzneimittel Description and Business Overview
    Table 49. Stada Arzneimittel Recombinant Peptide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 50. Stada Arzneimittel Product
    Table 51. Stada Arzneimittel Recent Development
    Table 52. Amgen Corporation Information
    Table 53. Amgen Description and Business Overview
    Table 54. Amgen Recombinant Peptide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 55. Amgen Product
    Table 56. Amgen Recent Development
    Table 57. Hospira Corporation Information
    Table 58. Hospira Description and Business Overview
    Table 59. Hospira Recombinant Peptide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 60. Hospira Product
    Table 61. Hospira Recent Development
    Table 62. Actavis Corporation Information
    Table 63. Actavis Description and Business Overview
    Table 64. Actavis Recombinant Peptide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 65. Actavis Product
    Table 66. Actavis Recent Development
    Table 67. Cipla Ltd. Corporation Information
    Table 68. Cipla Ltd. Description and Business Overview
    Table 69. Cipla Ltd. Recombinant Peptide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 70. Cipla Ltd. Product
    Table 71. Cipla Ltd. Recent Development
    Table 72. Wockhardt Ltd. Corporation Information
    Table 73. Wockhardt Ltd. Description and Business Overview
    Table 74. Wockhardt Ltd. Recombinant Peptide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 75. Wockhardt Ltd. Product
    Table 76. Wockhardt Ltd. Recent Development
    Table 77. Biocon Ltd. Corporation Information
    Table 78. Biocon Ltd. Description and Business Overview
    Table 79. Biocon Ltd. Recombinant Peptide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 80. Biocon Ltd. Product
    Table 81. Biocon Ltd. Recent Development
    Table 82. Key Raw Materials Lists
    Table 83. Raw Materials Key Suppliers Lists
    Table 84. Recombinant Peptide Customers List
    Table 85. Recombinant Peptide Distributors List
    Table 86. Research Programs/Design for This Report
    Table 87. Key Data Information from Secondary Sources
    Table 88. Key Data Information from Primary Sources
List of Figures
    Figure 1. Recombinant Peptide Product Picture
    Figure 2. Global Recombinant Peptide Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Recombinant Peptide Market Size 2017-2028 (US$ Million)
    Figure 4. Global Recombinant Peptide Sales 2017-2028 (K Units)
    Figure 5. United States Recombinant Peptide Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Recombinant Peptide Market Size 2017-2028 (US$ Million)
    Figure 7. United States Recombinant Peptide Sales 2017-2028 (K Units)
    Figure 8. United States Recombinant Peptide Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Recombinant Peptide Market Share in Global, in Volume (K Units) 2017-2028
    Figure 10. Recombinant Peptide Report Years Considered
    Figure 11. Product Picture of Glucagon
    Figure 12. Product Picture of Calcitonin
    Figure 13. Product Picture of Other
    Figure 14. Global Recombinant Peptide Market Share by Type in 2022 & 2028
    Figure 15. Global Recombinant Peptide Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 16. Global Recombinant Peptide Sales Market Share in Value by Type (2017-2028)
    Figure 17. Global Recombinant Peptide Sales by Type (2017-2028) & (K Units)
    Figure 18. Global Recombinant Peptide Sales Market Share in Volume by Type (2017-2028)
    Figure 19. Global Recombinant Peptide Price by Type (2017-2028) & (US$/Unit)
    Figure 20. United States Recombinant Peptide Market Share by Type in 2022 & 2028
    Figure 21. United States Recombinant Peptide Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 22. United States Recombinant Peptide Sales Market Share in Value by Type (2017-2028)
    Figure 23. United States Recombinant Peptide Sales by Type (2017-2028) & (K Units)
    Figure 24. United States Recombinant Peptide Sales Market Share in Volume by Type (2017-2028)
    Figure 25. United States Recombinant Peptide Price by Type (2017-2028) & (US$/Unit)
    Figure 26. Product Picture of Oncology
    Figure 27. Product Picture of Blood Disorders
    Figure 28. Product Picture of Infectious Diseases
    Figure 29. Product Picture of Autoimmune Diseases
    Figure 30. Product Picture of Other
    Figure 31. Global Recombinant Peptide Market Share by Application in 2022 & 2028
    Figure 32. Global Recombinant Peptide Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 33. Global Recombinant Peptide Sales Market Share in Value by Application (2017-2028)
    Figure 34. Global Recombinant Peptide Sales by Application (2017-2028) & (K Units)
    Figure 35. Global Recombinant Peptide Sales Market Share in Volume by Application (2017-2028)
    Figure 36. Global Recombinant Peptide Price by Application (2017-2028) & (US$/Unit)
    Figure 37. United States Recombinant Peptide Market Share by Application in 2022 & 2028
    Figure 38. United States Recombinant Peptide Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 39. United States Recombinant Peptide Sales Market Share in Value by Application (2017-2028)
    Figure 40. United States Recombinant Peptide Sales by Application (2017-2028) & (K Units)
    Figure 41. United States Recombinant Peptide Sales Market Share in Volume by Application (2017-2028)
    Figure 42. United States Recombinant Peptide Price by Application (2017-2028) & (US$/Unit)
    Figure 43. North America Recombinant Peptide Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 44. North America Recombinant Peptide Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 45. U.S. Recombinant Peptide Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Canada Recombinant Peptide Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Europe Recombinant Peptide Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 48. Europe Recombinant Peptide Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 49. Germany Recombinant Peptide Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. France Recombinant Peptide Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. U.K. Recombinant Peptide Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Italy Recombinant Peptide Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Russia Recombinant Peptide Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Asia-Pacific Recombinant Peptide Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 55. Asia-Pacific Recombinant Peptide Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 56. China Recombinant Peptide Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. Japan Recombinant Peptide Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. South Korea Recombinant Peptide Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. India Recombinant Peptide Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Australia Recombinant Peptide Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Taiwan Recombinant Peptide Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Indonesia Recombinant Peptide Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Thailand Recombinant Peptide Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Malaysia Recombinant Peptide Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 65. Philippines Recombinant Peptide Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Latin America Recombinant Peptide Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 67. Latin America Recombinant Peptide Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 68. Mexico Recombinant Peptide Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 69. Brazil Recombinant Peptide Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 70. Argentina Recombinant Peptide Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 71. Middle East & Africa Recombinant Peptide Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 72. Middle East & Africa Recombinant Peptide Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 73. Turkey Recombinant Peptide Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 74. Saudi Arabia Recombinant Peptide Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 75. UAE Recombinant Peptide Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 76. Recombinant Peptide Value Chain
    Figure 77. Recombinant Peptide Production Process
    Figure 78. Channels of Distribution
    Figure 79. Distributors Profiles
    Figure 80. Bottom-up and Top-down Approaches for This Report
    Figure 81. Data Triangulation
    Figure 82. Key Executives Interviewed